This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Tronox Holding's acquisition of Tizir Titanium and Iron raises competition concerns, CMA says

( January 4, 2021, 07:32 GMT | Official Statement) -- MLex Summary: Tronox Holding's proposed acquisition of Tizir Titanium and Iron raises competition concerns, the UK's Competition and Markets Authority said. The deal combines a manufacturer of titanium-dioxide pigment with the Norwegian titanium-smelting facility of French mining company Eramet. The CMA said Tronox intends to use all of TTI’s chloride slag in its own production of titanium dioxide and halt future sales of chloride slag to third parties. This would leave Rio Tinto, TTI’s main chloride slag competitor, with what is "effectively a monopoly position," the CMA said. The CMA said it has found that the removal of TTI as a main competitor from the market could significantly limit customer supply and lead to higher prices for chloride slag globally, as well as for titanium dioxide in the UK and Europe. Statements follow....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login